Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Maletzki

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Digestive Diseases (Basel, Switzerland)|November 20, 2010
Inflammation and immunity in the tumor environmentC Maletzki, J Emmrich
Gut|November 21, 2007
Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse modelC Maletzki, M Linnebacher, B Kreikemeyer, et al.
Clinical & Developmental Immunology|November 30, 2012
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's ToxinC Maletzki, U Klier, W Obst, et al.
Immuno-Oncology Technology|June 15, 2026
Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancerP Meißner, P Kaps, T Momper, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Digestive Diseases (Basel, Switzerland)|November 20, 2010
Inflammation and immunity in the tumor environmentC Maletzki, J Emmrich
Gut|November 21, 2007
Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse modelC Maletzki, M Linnebacher, B Kreikemeyer, et al.
Clinical & Developmental Immunology|November 30, 2012
Reevaluating the concept of treating experimental tumors with a mixed bacterial vaccine: Coley's ToxinC Maletzki, U Klier, W Obst, et al.
Immuno-Oncology Technology|June 15, 2026
Th17-mediated antitumor immunity in patient-derived organoid and autologous immune cell cocultures predicts response to immunotherapy in head and neck cancerP Meißner, P Kaps, T Momper, et al.
Pageof 1